These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39270149)

  • 1. Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease.
    Son HJ; Kim JS; Bateman RJ; Kim S; Llibre-Guerra JJ; Day GS; Chhatwal JP; Berman SB; Schofield PR; Jucker M; Levin J; Lee JH; Perrin RJ; Morris JC; Cruchaga C; Hassenstab J; Salloway SP; Lee JH; Daniels A;
    Neurology; 2024 Oct; 103(7):e209766. PubMed ID: 39270149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia.
    Day GS; Cruchaga C; Wingo T; Schindler SE; Coble D; Morris JC
    JAMA Netw Open; 2019 Oct; 2(10):e1913491. PubMed ID: 31617930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Schultz SA; Liu L; Schultz AP; Fitzpatrick CD; Levin R; Bellier JP; Shirzadi Z; Joseph-Mathurin N; Chen CD; Benzinger TLS; Day GS; Farlow MR; Gordon BA; Hassenstab JJ; Jack CR; Jucker M; Karch CM; Lee JH; Levin J; Perrin RJ; Schofield PR; Xiong C; Johnson KA; McDade E; Bateman RJ; Sperling RA; Selkoe DJ; Chhatwal JP;
    Lancet Neurol; 2024 Sep; 23(9):913-924. PubMed ID: 39074479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.
    Day GS; Musiek ES; Roe CM; Norton J; Goate AM; Cruchaga C; Cairns NJ; Morris JC
    JAMA Neurol; 2016 Sep; 73(9):1125-32. PubMed ID: 27454811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).
    Storandt M; Balota DA; Aschenbrenner AJ; Morris JC
    Neuropsychology; 2014 Jan; 28(1):19-29. PubMed ID: 24219606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.
    Prescott JW; Doraiswamy PM; Gamberger D; Benzinger T; Petrella JR;
    Radiology; 2022 Jan; 302(1):143-150. PubMed ID: 34636637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease.
    Lim YY; Maruff P; Barthélemy NR; Goate A; Hassenstab J; Sato C; Fagan AM; Benzinger TLS; Xiong C; Cruchaga C; Levin J; Farlow MR; Graff-Radford NR; Laske C; Masters CL; Salloway S; Schofield PR; Morris JC; Bateman RJ; McDade E;
    JAMA Neurol; 2022 Mar; 79(3):261-270. PubMed ID: 35099506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease.
    Llibre-Guerra JJ; Li Y; Schindler SE; Gordon BA; Fagan AM; Morris JC; Benzinger TLS; Hassenstab J; Wang G; Allegri R; Berman SB; Chhatwal J; Farlow MR; Holtzman DM; Jucker M; Levin J; Noble JM; Salloway S; Schofield P; Karch C; Fox NC; Xiong C; Bateman RJ; McDade E
    JAMA Netw Open; 2019 Dec; 2(12):e1917126. PubMed ID: 31825500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.
    Aguirre-Acevedo DC; Lopera F; Henao E; Tirado V; Muñoz C; Giraldo M; Bangdiwala SI; Reiman EM; Tariot PN; Langbaum JB; Quiroz YT; Jaimes F
    JAMA Neurol; 2016 Apr; 73(4):431-8. PubMed ID: 26902171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Tang M; Ryman DC; McDade E; Jasielec MS; Buckles VD; Cairns NJ; Fagan AM; Goate A; Marcus DS; Xiong C; Allegri RF; Chhatwal JP; Danek A; Farlow MR; Fox NC; Ghetti B; Graff-Radford NR; Laske C; Martins RN; Masters CL; Mayeux RP; Ringman JM; Rossor MN; Salloway SP; Schofield PR; Morris JC; Bateman RJ;
    Lancet Neurol; 2016 Dec; 15(13):1317-1325. PubMed ID: 27777020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Wang G; Coble D; McDade EM; Hassenstab J; Fagan AM; Benzinger TLS; Bateman RJ; Morris JC; Xiong C;
    Alzheimers Dement; 2019 Apr; 15(4):506-514. PubMed ID: 30773445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
    JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional connectivity in autosomal dominant and late-onset Alzheimer disease.
    Thomas JB; Brier MR; Bateman RJ; Snyder AZ; Benzinger TL; Xiong C; Raichle M; Holtzman DM; Sperling RA; Mayeux R; Ghetti B; Ringman JM; Salloway S; McDade E; Rossor MN; Ourselin S; Schofield PR; Masters CL; Martins RN; Weiner MW; Thompson PM; Fox NC; Koeppe RA; Jack CR; Mathis CA; Oliver A; Blazey TM; Moulder K; Buckles V; Hornbeck R; Chhatwal J; Schultz AP; Goate AM; Fagan AM; Cairns NJ; Marcus DS; Morris JC; Ances BM
    JAMA Neurol; 2014 Sep; 71(9):1111-22. PubMed ID: 25069482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    O'Connor A; Karikari TK; Poole T; Ashton NJ; Lantero Rodriguez J; Khatun A; Swift I; Heslegrave AJ; Abel E; Chung E; Weston PSJ; Pavisic IM; Ryan NS; Barker S; Rossor MN; Polke JM; Frost C; Mead S; Blennow K; Zetterberg H; Fox NC
    Mol Psychiatry; 2021 Oct; 26(10):5967-5976. PubMed ID: 32665603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
    Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
    JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.
    McDade E; Wang G; Gordon BA; Hassenstab J; Benzinger TLS; Buckles V; Fagan AM; Holtzman DM; Cairns NJ; Goate AM; Marcus DS; Morris JC; Paumier K; Xiong C; Allegri R; Berman SB; Klunk W; Noble J; Ringman J; Ghetti B; Farlow M; Sperling RA; Chhatwal J; Salloway S; Graff-Radford NR; Schofield PR; Masters C; Rossor MN; Fox NC; Levin J; Jucker M; Bateman RJ;
    Neurology; 2018 Oct; 91(14):e1295-e1306. PubMed ID: 30217935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.